#USA #Boston #AI Technology #LifeSphere #ArisGlobal

ArisGlobal Accelerates Growth and AI Adoption

ArisGlobal, a technology leader in the life sciences sector, has reported significant results for the year 2025, showcasing a remarkable increase in customer engagement and the successful deployment of their AI-driven tools. This surge can be attributed to their flagship product, LifeSphere®, which has become a cornerstone for pharmaceutical and life sciences organizations striving to modernize their IT operations.

Customer Growth and Expansion

During 2025, ArisGlobal saw an impressive increase in demand for AI-supported modernization. Companies in the life sciences industry are facing overwhelming data volumes, operational complexities, and regulatory pressures, demanding innovative solutions. The highlights of this growth included:

• - Over 100 new clients and expansions in existing LifeSphere subscriptions.
• - A staggering 125% increase in clients for NavaX, especially in regulatory and safety operations.

This acceleration in customer trust reflects ArisGlobal's capability to deliver measurable outcomes, with many organizations moving towards broader, cross-functional applications of their tools beyond initial implementations. Steve Nuckols, Head of Customer Management, emphasized that clients are no longer experimenting with AI; they are fully integrating it into their operational frameworks.

Global Implementations and Large-Scale Rollouts

In 2025, ArisGlobal successfully completed 38 global implementations, reinforcing its reputation as a provider of complex, enterprise-wide programs. The breakdown included:

• - 22 implementations focused on safety screening.
• - 11 significant regulatory implementations.
• - 5 deployments of NavaX features across various client platforms.

These implementations were notably for three of the world's top ten pharmaceutical companies and included early deployments of advanced AI functionalities. Raj Hattarki, Chief Operations Officer, noted the urgency with which their teams work, echoing the pressures their clients face daily. Despite the complexity of the projects, they managed to bring clients into full production swiftly while maintaining compliance and a solid foundation for long-term success.

Product Innovations from AI Functions to Intelligent Orchestration

Throughout 2025, ArisGlobal made significant strides in product development, transitioning LifeSphere from isolated AI functionalities to a more integrated, intelligence-driven operational model. Key new offerings included:

• - Unify: A data orchestration layer that consolidates safety, regulation, quality, and medical data, creating a unified foundation for cross-domain transparency and decision-making.
• - NavaX Insights: This product turns operational and safety data into actionable intelligence through real-time analytics, trend spotting, and performance monitoring.
• - NavaX Agents: The introduction of agent-based AI functionalities into safety and regulation sectors.

NavaX currently supports clients dealing with 700,000 cases annually, with expectations to handle up to 2.5 million cases by mid-2026. The innovative leadership of ArisGlobal was recognized with the Frost & Sullivan 2025 New Product Innovation Award, underlining their commitment to responsible AI practices in regulated environments.

Looking Ahead

Building on the success and momentum of 2025, ArisGlobal aims to scale its AI applications further in 2026, expanding its role as partners in data analysis and technology for global life sciences firms. CEO Aman Wasan noted that 2025 marked a pivotal shift, where AI transformed from concept to a source of tangible results. As AI enters mainstream enterprise usage, the focus is on intelligent orchestration, design-driven trust, and delivering outcomes crucial for patients, regulatory bodies, and support teams.

For those interested in following ArisGlobal's journey and updates, additional information can be found on their LinkedIn profile and official website.